These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8992625)

  • 1. [Tuberculosis therapy in canton Zurich 1991-1993: what are the causes for recurrence and therapy failure?].
    Rose N; Shang H; Pfyffer GE; Brändli O
    Schweiz Med Wochenschr; 1996 Nov; 126(48):2059-67. PubMed ID: 8992625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients.
    Lopez-Cortes LF; Marin-Niebla A; Lopez-Cortes LE; Villanego I; Rodriguez-Diez M; Pascual-Carrasco R
    Int J Tuberc Lung Dis; 2005 Dec; 9(12):1385-90. PubMed ID: 16466062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
    Brändli O; Häcki MA; Scheel A; Stiefel M
    Schweiz Med Wochenschr; 1983 Jan; 113(3):92-6. PubMed ID: 6828844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directly observed therapy in an inner city hospital.
    Smirnoff M; Goldberg R; Indyk L; Adler JJ
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):134-9. PubMed ID: 9562124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-tuberculosis chemotherapy].
    Wada M
    Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TB news.
    Posit Aware; 1996; 7(1):6-7. PubMed ID: 11363128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
    Szklo A; Mello FC; Guerra RL; Dorman SE; Muzy-de-Souza GR; Conde MB
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):775-80. PubMed ID: 17609053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program.
    Salomon N; Perlman DC; Rubenstein A; Mandelman D; McKinley FW; Yancovitz SR
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):397-404. PubMed ID: 9441092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City.
    Driver CR; Munsiff SS; Li J; Kundamal N; Osahan SS
    Clin Infect Dis; 2001 Nov; 33(10):1762-9. PubMed ID: 11595988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis.
    Weis SE; Slocum PC; Blais FX; King B; Nunn M; Matney GB; Gomez E; Foresman BH
    N Engl J Med; 1994 Apr; 330(17):1179-84. PubMed ID: 8139628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of increasing incentives on adherence to tuberculosis directly observed therapy.
    Davidson H; Schluger NW; Feldman PH; Valentine DP; Telzak EE; Laufer FN
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):860-5. PubMed ID: 10985655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles of therapy for tuberculosis.
    Ortona L; Antinori A
    Rays; 1998; 23(1):181-92. PubMed ID: 9673144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.